EA Pharma is a pharmaceutical company that focuses on the development and commercialization of drugs for gastrointestinal diseases and other gastrointestinal-related conditions. Founded in 2016, the company prioritizes research and development in the field of gastroenterology, with a focus on addressing unmet medical needs in this therapeutic area. Their portfolio may include medications for conditions such as inflammatory bowel disease, irritable bowel syndrome, and gastrointestinal cancers.